Thornburg Investment Management Inc Grifols Sa Transaction History

Thornburg Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$17.44 - $21.53 $13.6 Million - $16.8 Million	-778,446 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$19.97 - $21.96 $3.4 Million - $3.74 Million	170,259 Added 27.99%	778,446 $16.6 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $2 Million - $2.45 Million	99,343 Added 19.52%	608,187 $13.1 Million
Q1 2018 May 07, 2018	BUY	$20.31 - $24.95 $2.02 Million - $2.48 Million	99,564 Added 24.33%	508,844 $10.8 Million
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $1.49 Million - $1.7 Million	71,139 Added 21.04%	409,280 $9.38 Million
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $1.23 Million - $1.34 Million	61,167 Added 22.08%	338,141 $7.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	276,974	276,974 $5.85 Million

162

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.8B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.